Newer dopaminergic agents cause minimal endocrine effects in idiopathic Parkinson's disease (Q33572858)

28 July 2017

title

Newer dopaminergic agents cause minimal endocrine effects in idiopathic Parkinson's disease (English)

1 reference

28 July 2017

1 reference

1 reference

Lakdasa Premawardhana

object named as

Lakdasa D Premawardhana

6

0 references

author name string

Jacob S Daniel

1

1 reference

28 July 2017

Jyothish P Govindan

2

1 reference

28 July 2017

Chandan Kamath

3

1 reference

28 July 2017

Charles D'Souza

4

1 reference

28 July 2017

Mohamed A Adlan

5

1 reference

28 July 2017

publication date

1 May 2014

1 reference

Clinical medicine insights. Endocrinology and diabetes

28 July 2017

published in

1 reference

28 July 2017

volume

7

1 reference

28 July 2017

page(s)

13-17

1 reference

Pituitary adenomas: an overview

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Medical treatment of Cushing's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Prolactin--not only lactotrophin. A "new" view of the "old" hormone.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Melatonin and mitochondrial dysfunction in the central nervous system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Bromocriptine and dopamine receptor stimulation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Somatostatin-dopamine chimeras: a novel approach to treatment of neuroendocrine tumors.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Diurnal salivary cortisol concentrations in Parkinson's disease: increased total secretion and morning cortisol concentrations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Treatment of persistent and recurrent acromegaly

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Long-term management with octreotide or cabergoline in ectopic corticotropin hypersecretion: case report and literature review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Prolactin: a pleiotropic neuroendocrine hormone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

A study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Effects of terguride on anterior pituitary function in parkinsonian patients treated with L-dopa: a double-blind study versus placebo

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Role of dopamine in the regulation of growth hormone secretion: dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated Parkinson's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Patients with Parkinson disease: functional analysis of dopamine receptors by bromocriptine- thyrotropin-releasing hormone test

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Endocrine effects of bromocryptin in patients with Parkinsonism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Effect of Dopamine Agonist (Lergotrile Mesylate) Therapy on Twenty-Four Hour Secretion of Prolactin in Treated Parkinson's Disease*

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Diurnal secretion profiles of growth hormone, thyrotrophin and prolactin in Parkinson's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Pituitary function and the somatotrophic system in patients with idiopathic Parkinson's disease under chronic dopaminergic therapy

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Defective 5-HT1 -Receptor-Mediated Neurotransmission in the Control of Growth Hormone Secretion in Parkinson’s Disease

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011722

Neuroendocrine and side effect profile of pramipexole, a new dopamine receptor agonist, in humans

31 October 2018

1 reference

12 December 2020

Prolactin secretion in Parkinson disease

1 reference

12 December 2020

1 reference

12 December 2020

Restoration of ACTH/cortisol and LH responses to naloxone by chronic dopaminergic treatment in Parkinson's disease

1 reference

12 December 2020

Reduced luteinizing hormone secretion in women with Parkinson's disease

1 reference

12 December 2020

Function of dopamine receptors in Parkinson's disease: prolactin responses

1 reference

12 December 2020

Identifiers

DOI

10.4137/CMED.S14902

1 reference

28 July 2017

1 reference

28 July 2017

1 reference